Navigation Links
Medical molecules designed to respond to visible light that can penetrate tissue

If you have ever covered a flashlight with your hand and seen the red light that still comes through, then you have seen light in the therapeutic window ?that magic wavelength that is not absorbed or reflected away by tissue. Scientists believe that they can use light at that wavelength to signal manmade molecules to release drugs at disease sites in the body.

Such possibilities will be discussed in a poster and a talk by Virginia Tech researchers presenting at the 229th American Chemical Society national meeting in San Diego on March 13-17.

Researchers in Karen Brewer's group at Virginia Tech have designed supramolecular complexes that can hold and, when signaled by light (photoinitiatied), will generate pharmaceutical compounds that can cleave DNA, such as in a tumor cell. "The challenge has been that tissue blocks light so we can't signal molecules deep within the body to deliver drug therapy," says Brewer, associate professor of chemistry.

Matthew Mongelli of Maywood N.J., a postdoctoral associate in chemistry, and his colleagues in chemistry and biology at Virginia Tech, have been working with Theralase Technologies Inc. to design molecular systems that use light that is in the therapeutic window. Starting with a complex with known DNA cleaving qualities, they changed the light absorber unit to one that responds to the red wavelength.

"Investigations into polyazine supermolecular complexes containing Ru and Os with Rh centers that possess photoactive MMCT states: Visible light induced, oxygen independent DNA photocleavage (INOR 329)," will be presented by Mongelli during the general poster session, 7 to 9 p.m., Sunday, March 13, in Convention Center Hall D. The poster has also been selected for the Sci_Mix session 7 to 9 p.m. Monday, March 14, in the Convention Center's Sails Pavilion.

Co-authors are Brewer; undergraduate chemistry students Matthew Jeletic of Centreville, Va. and Jerita Dubash of Ashburn, Va.; and Biology
'"/>

Source:Virginia Tech


Page: 1 2

Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Medical whistleblowers speak out
3. Medical experts: US unlikely to have enough vaccines to stop avian flu
4. Inflammatory molecules released by pollen trigger allergies
5. DNA constraints control structure of attached macromolecules
6. Scientists discover that three molecules may be developed into new Alzheimers drugs
7. Physical and functional interaction of key cell growth molecules linked to cancer
8. Scientists discover new way to look at how molecules twist and turn on water
9. Scientists learn to predict protein-stabilizing ability of small molecules
10. Tiny RNA molecules fine-tune the brains synapses
11. Convergent evolution of molecules in electric fish

Post Your Comments:
(Date:11/23/2009)... Applied mathematicians dissected the morphology ...cteristic long leaf with a saddle-like arc midsect...e simple cause of the lily,s fan-like shapeelastic...tial growthwas revealed by using an equally simple...ng, a postdoctoral student at Harvard,s School of ...
(Date:11/23/2009)... "incontrovertible evidence" that the volcanic sup... 73,000 years ago deforested much of central India... report. , The volcano ejected an estimated 800 ...ng a crater (now the world,s largest volcanic lake...de. Ash from the event has been found in India, th...
(Date:11/23/2009)...hire microbiologist Louis Tisa has received two gr... the actinorhizal plants, widespread woody plants ...nated soils. , The United States Department of ...lecular, cellular and biomedical sciences, $399,00...e bacteria Frankia and Casuarina, an actinorhizal ...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 1More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 2More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 3More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 4VivaGel 28R 29 Demonstrates Anti HIV and Herpes Activity Following Human Administration 53604 1VivaGel 28R 29 Demonstrates Anti HIV and Herpes Activity Following Human Administration 53604 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6
...overed dozens of potentially beneficial bioactive ... Amazon rain forest, including several so genetica... new taxonomical genera. , The analysis of 135 en...ing within the inner tissue of plants - by members...se at Yale will be published Monday in the journal...
...ll package sizes these days, presumably to help co...the Journal of Consumer Research found that peop...they are in small packages than large ones. And sm...to temptation in the first place. , Authors Rita ...ik Pieters, and Marcel Zeelenberg (both Tilburg Un...
...to access 3D images of biomacromolecules underlyin...lying on text to provide the understanding of biom...alled Proteopedia now provides a new resource by l...tructural information. The wiki web resource, firs...l Genome Biology, displays protein structures and ...
Other Biology News:Yale undergrads' Amazon trip yields a treasure trove of diversity 2Pay attention! Small packages may lead to overeating 2
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceut...(PTO)hasallowedthepatentapplicationfor,itsnano-par...logyisahighlyefficientapproachtoincorporatepeptide...oraldeliveryofdrugs,otherwiseadministeredasinjecti...pliedtomanymacromoleculardrugssuchasinsulin,interf...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCor...velopmentAuthority(OPDA)wererecentlyawarded$2milli...onBoard(CERB)inaprivate/publicpartnershiptoconstru...LincolnCounty,WA. ,, "Thisinvestmentwillsignifi...ver70greenjobstoLincolnCounty,"saidBlueMarbleEnerg...
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire...CalottoCapitalInc.,aleadingproviderofadvancedlaser...ilityclinicmarkets,todayreportedoperationalandfina...9. , ,Q32009Highlights,-Revenuewas$1.46millionco...as66.3percentcomparedwith66.1percentinQ3,2008,-Net...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/...hatRandyScott,GenomicHealth,sExecutiveChairman,wil...renceinNewYorkCityonTuesday,December1,2009at10:00a...dwebcastofthepresentation,visittheInvestorRelation....genomichealth.com .Pleaseconnecttothewebsiteatlea...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ented at the 12th World Conference on Lung Cancer ...wire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI ...entifies,develops and commercializes differentiate...positive preliminary results from the first two co... nimotuzumab in combination with,radiation for the...
...0 Split Effective at Close of Business Today ... PLANTATION, Fla., Sept. 4 Viragen,International,... subsidiary,of Viragen, Inc. (OTC Bulletin Board: ... reverse stock split of its issued and outstanding...f business today, September 4, 2007. The reverse ...
... Sept. 4 American Oriental,Bioengineering, Inc. (...or of,plant-based pharmaceutical and nutraceutical...ny will attend the Credit Suisse Asian Technology,...henzhen, China as well as,the 3rd Semi-Annual Inve...,Carret & Co. on September 11, 2007 in Beijing, Ch...
Other Biology Technology:YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 2YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 3YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 4YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 5Viragen International to Reverse Split Its Common Stock 2Viragen International to Reverse Split Its Common Stock 3American Oriental Bioengineering Announces Participation in September Investor Conferences 2
BD BioCoat Collagen IV 150 mm Culture Dishes from BD Biosciences - Discovery Labware
Chicken Anti-Polymerase (RNA) II (DNA directed) polypeptide L Antibody, Unconjugated from CHEMICON
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Human Apoptosis Kit 50 tests from BD Biosciences Pharmingen
Biology Products: